PF-06439015 mesylate

DESCRIPTION

PF-06439015 overcomes clinical ALK (receptor tyrosine kinase anatropic lymphoma kinase) mutations resistant to krizotinib. Pf-06439015 is an effective selective inhibitor.

DETAILS

Cas: 1549629-82-4
Purity: 98%
Smiles: [C@@H](OC=1C=C(C=NC1N)C=2SC([C@](CO)(C)O)=NC2C)(C)C3=C(C=CC(F)=C3)N4N=CC=N4
Category: Compound
Molecular Weight: 470.52
Molecular Formula: C22H23FN6O3S

Lead Time: 4 - 5 weeks